{"DataElement":{"publicId":"5589229","version":"1","preferredName":"Participant Enrollment Clinical Study Disease Name","preferredDefinition":"A description of the clinical study disease that the participant was enrolled in.","longName":"2746537v1.0:5589206v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2746537","version":"1","preferredName":"Participant Enrollment","preferredDefinition":"The entering of an individual who takes part in an activity onto a record or list.","longName":"2407061v1.0:2433477v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2407061","version":"1","preferredName":"Participant","preferredDefinition":"Someone who takes part in an activity.","longName":"C29867","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Participant","conceptCode":"C29867","definition":"Someone who takes part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0149E795-49C5-054B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-09-21","modifiedBy":"ONEDATA","dateModified":"2005-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2433477","version":"1","preferredName":"Enrollment","preferredDefinition":"Enrollment; to insert, register, or enter in a list, catalog, or roll. (Merriam-Webster Online)","longName":"C37948","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enrollment","conceptCode":"C37948","definition":"The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-ED49-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C465165-A06D-1674-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-05-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5589206","version":"1","preferredName":"Clinical Study Disease Name","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The words or language units by which a thing is known.","longName":"5589206v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Multiple myeloma","valueDescription":"Plasma Cell Myeloma","ValueMeaning":{"publicId":"2559811","version":"1","preferredName":"Plasma Cell Myeloma","longName":"2559811","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42ED6358-6944-701F-E053-F662850ADF5C","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Myelodysplastic syndrome (MDS)","valueDescription":"Myelodysplastic Syndrome","ValueMeaning":{"publicId":"3946618","version":"1","preferredName":"Myelodysplastic Syndrome","longName":"3946618","preferredDefinition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome","conceptCode":"C3247","definition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA87B0E5-6712-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"GDEEN","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42ED6358-694E-701F-E053-F662850ADF5C","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Myelofibrosis","valueDescription":"Myelofibrosis","ValueMeaning":{"publicId":"4264965","version":"1","preferredName":"Myelofibrosis","longName":"4264965","preferredDefinition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelofibrosis","conceptCode":"C3248","definition":"A partial or complete replacement of the bone marrow stroma by fibrous tissue.  It can be a primary bone marrow lesion as part of the chronic myeloproliferative disorders (chronic idiopathic myelofibrosis), a manifestation of acute myeloid leukemia (acute panmyelosis with myelofibrosis), or a secondary phenomenon due to bone marrow involvement by a metastatic tumor (e.g., metastatic breast carcinoma). --2003","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3B91-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42ED6358-6958-701F-E053-F662850ADF5C","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Sickle cell disease","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"53F5DDB1-4727-5FFE-E053-F662850AE277","beginDate":"2017-07-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-10","modifiedBy":"ONEDATA","dateModified":"2017-07-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5595994","version":"1","preferredName":"Clinical Study Disease or Disorder Name","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:The words or language units by which a thing is known.","longName":"C15206:C2991:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43137719-F9C9-1777-E053-F662850A6D12","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-07","modifiedBy":"ONEDATA","dateModified":"2016-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42ED6358-682A-701F-E053-F662850ADF5C","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"KUMMEROA","dateModified":"2017-07-10","changeDescription":". Added PV for 2554r2. AK 6/29/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMSR_RC_enrol_std_cms","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the clinical study d","type":"Preferred Question Text","description":"What was the clinical study disease that the participant was enrolled in?","url":null,"context":"NHLBI"},{"name":"The recipient should be enrolled on the following study","type":"Alternate Question Text","description":"The recipient should be enrolled on the following study","url":null,"context":"NHLBI"},{"name":"The recipient should be enrolled on the following study","type":"Application Standard Question Text","description":"The recipient should be enrolled on the following study","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42ED7C71-708B-703A-E053-F662850ACA46","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-05","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}